Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNA MIAT correlates with immune infiltrates and drug reactions in hepatocellular carcinoma
Lirong Peng, Yiyin Chen, Qiaoping Ou, et al.
International Immunopharmacology (2020) Vol. 89, pp. 107071-107071
Closed Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Applications of single-cell sequencing in cancer research: progress and perspectives
Yalan Lei, Rong Tang, Jin Xu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 356
The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy
Wenxiao Jiang, Shuya Pan, Xin Chen, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 120
Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma
Hongjun Xie, Muqi Shi, Yifei Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Silencing lncRNA HCG18 regulates GPX4-inhibited ferroptosis by adsorbing miR-450b-5p to avert sorafenib resistance in hepatocellular carcinoma
X. Li, Yunhui Li, Peilong Lian, et al.
Human & Experimental Toxicology (2023) Vol. 42
Open Access | Times Cited: 37
Puzzling out the role of MIAT LncRNA in hepatocellular carcinoma
Rawan Amr Elmasri, Alaa A. Rashwan, Sarah Hany Gaber, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 547-559
Open Access | Times Cited: 11
Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy
Lokesh Kadian, Deepika Verma, Neelam Lohani, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 12, pp. 3229-3254
Closed Access | Times Cited: 8
Long Non-coding RNAs: Mechanisms, Experimental, and Computational Approaches in Identification, Characterization, and Their Biomarker Potential in Cancer
Anshika Chowdhary, Venkata Satagopam, Reinhard Schneider
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 51
The role of LncRNAs in tumor immunotherapy
Xuan Pan, Chenchen Li, Jifeng Feng
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 22
2,5-dimethylcelecoxib alleviated NK and T-cell exhaustion in hepatocellular carcinoma via the gastrointestinal microbiota-AMPK-mTOR axis
Banglun Pan, Zhanfei Chen, Xiaoxia Zhang, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006817-e006817
Open Access | Times Cited: 20
Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma
Yang Bai, Haiping Lin, Jiaqi Chen, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 34
The current status and future of PD-L1 in liver cancer
Liyuan Hao, Shenghao Li, Jiali Deng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
An Overview of the Immune Modulatory Properties of Long Non-Coding RNAs and Their Potential Use as Therapeutic Targets in Cancer
Moisés Martínez‐Castillo, Abdelrahman M. Elsayed, Gabriel López-Berestein, et al.
Non-Coding RNA (2023) Vol. 9, Iss. 6, pp. 70-70
Open Access | Times Cited: 13
lncRNA MIAT targets miR‐411‐5p/STAT3/PD‐L1 axis mediating hepatocellular carcinoma immune response
Xiaoxia Zhang, Banglun Pan, Jiacheng Qiu, et al.
International Journal of Experimental Pathology (2022) Vol. 103, Iss. 3, pp. 102-111
Open Access | Times Cited: 22
Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential
Han Qin, Mengchen Wang, Xi Dong, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma—From m6A Modification to Blood Biomarkers
Jung Woo Eun, Jae Youn Cheong, Jee‐Yeong Jeong, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2272-2272
Open Access | Times Cited: 11
MIAT: A pivotal oncogenic long noncoding RNA tunning the hallmarks of solid malignancies
Monica Mosaad Rostom, Alaa A. Rashwan, Christina D. Sotiropoulou, et al.
Translational Oncology (2025) Vol. 54, pp. 102329-102329
Closed Access
Regulation of immune-mediated chemoresistance in cancer by lncRNAs: an in-depth review of signaling pathways
Saade Abdalkareem Jasim, Farag M. A. Altalbawy, Subasini Uthirapathy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Long non-coding rnas as key modulators of the immune microenvironment in hepatocellular carcinoma: implications for Immunotherapy
Siqi Zhao, Fei Chen, Lingyu Hu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Suppression of Th17 cell differentiation via sphingosine-1-phosphate receptor 2 by cinnamaldehyde can ameliorate ulcerative colitis
Shulan Qu, Long Chen, Xueshan Wen, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 134, pp. 111116-111116
Open Access | Times Cited: 24
DISCERN: deep single-cell expression reconstruction for improved cell clustering and cell subtype and state detection
Fabian Hausmann, Can Ergen, Robin Khatri, et al.
Genome biology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Identification of ribosomal protein family as immune-cell-related biomarkers of NAFLD by bioinformatics and experimental analyses
Gerui Li, Hang Li, Ze Chen
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8
A Novel Pyroptotic and Inflammatory Gene Signature Predicts the Prognosis of Cutaneous Melanoma and the Effect of Anticancer Therapies
Yujian Xu, Youbai Chen, Zehao Niu, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 12
Roles of long noncoding RNAs on tumor immune escape by regulating immune cells differentiation and function.
Lisha Chang, Juan Li, Hao Ji, et al.
American Journal of Cancer Research (2021) Vol. 11, Iss. 6, pp. 2369-2385
Closed Access | Times Cited: 14
Dysregulation of non-coding RNAs mediates cisplatin resistance in hepatocellular carcinoma and therapeutic strategies
Xu‐Feng Xu, Xiao‐Ke Yang, Yang Song, et al.
Pharmacological Research (2021) Vol. 176, pp. 105906-105906
Closed Access | Times Cited: 13
Identification of A Risk Signature Based on Lactic Acid Metabolism-Related LncRNAs in Patients With Esophageal Squamous Cell Carcinoma
Fangchao Zhao, Yishuai Li, Zefang Dong, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top